Osteoarthritis Therapeutics Market by Anatomy (Knee, Hip), Drug Type (NSAIDs, Corticosteroids), Route of Administration (Parenteral, Topical), Distribution Channel (Hospital Pharmacies), Purchasing Pattern (Prescription Drugs) - Global Forecast to 2024

Publisher Name :
Date: 15-Oct-2019
No. of pages: 147
Inquire Before Buying

“The osteoarthritis therapeutics market is projected to register a CAGR of 8.1% during the forecast period.”

The osteoarthritis therapeutics market is projected to reach USD 10.1 billion by 2024 from USD 6.8 billion in 2019, at a CAGR of 8.1%. Growth in this industry is driven by the rapid growth in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease. On the other hand, the availability of alternative non-drug pain management therapies is a major market challenge.

“Knee osteoarthritis segment to witness the highest growth during the forecast period.”

Based on anatomy, the osteoarthritis therapeutics market is segmented into knee, hip, hand, and small-joint. The knee osteoarthritis segment is projected to grow at the highest CAGR during the forecast period. A large number of patients suffering from knee osteoarthritis is the major factor supporting the growth of this segment.

“Visco supplementation agents segment to register the highest growth in the osteoarthritis therapeutics market during the forecast period.”

Based on drug type, the osteoarthritis therapeutics market is segmented into visco supplementation agents, nonsteroidal anti-inflammatory drugs (NSAIDs), analgesics, and corticosteroids. The analgesics segment is sub-segmented into duloxetine and acetaminophen, while the NSAIDs segment is sub-segmented into naproxen, aspirin, diclofenac, ibuprofen, and other molecules. The visco supplementation agents segment is projected to witness the highest growth in the osteoarthritis therapeutics market during the forecast period. The rising incidence of knee osteoarthritis is one of the major factors supporting the growth of this segment.

“Asia Pacific is estimated to register the highest CAGR during the forecast period.”

In this report, the osteoarthritis therapeutics market is segmented into four major regional segments, namely, Europe, North America, Asia Pacific, and the Rest of the World (RoW). The market in Asia-Pacific is projected to register the highest growth rate during the forecast period. The growth in this market is driven primarily by the rising incidence and prevalence of osteoarthritis, increasing geriatric and obese populations, and healthcare infrastructure improvements in several APAC countries.

Breakdown of Profiles of Primary Participants:


  • By Company Type: Tier 1: 20%, Tier 2: 45%, and Tier 3: 35%

  • By Designation: C-level: 30%, Director-level: 20%, and Others: 50%

  • By Region: North America: 35%, Europe: 24%, Asia Pacific: 25%, and the Rest of the World: 16%


Key players in the osteoarthritis therapeutics market include Sanofi (France), Horizon Therapeutics (Ireland), Johnson & Johnson (US), GlaxoSmithKline Plc (UK), Bayer AG (Germany), Abbott (US), Pfizer (US), Eli Lilly (US), Anika Therapeutics (US), and Flexion Therapeutics (US).

Research Coverage:

The report analyzes the osteoarthritis therapeutics market by anatomy, drug type, route of administration, distribution channel, purchasing pattern, and region. Apart from comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by market players over the last three years. In addition, the company profiles include the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the market.

Key Benefits of Buying the Report:

This report will enable both established firms and new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help these firms garner greater market shares. Firms purchasing the report can use any one,or a combination of the below mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:


  • Market Penetration: Comprehensive information on the product portfolios of the top players in the osteoarthritis therapeutics market

  • Product Development/Innovation: Detailed insights on the product approvals, R&D activities, and product launches in the osteoarthritis therapeutics market

  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the osteoarthritis therapeutics market

  • Market Development: Detailed information about emerging markets. The report analyzes the market for various osteoarthritis therapeutics across geographies

  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the osteoarthritis therapeutics market

Osteoarthritis Therapeutics Market by Anatomy (Knee, Hip), Drug Type (NSAIDs, Corticosteroids), Route of Administration (Parenteral, Topical), Distribution Channel (Hospital Pharmacies), Purchasing Pattern (Prescription Drugs) - Global Forecast to 2024

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Osteoarthritis Therapeutics Market Overview
4.2 Europe: Market Share, By Anatomy (2018)
4.3 Geographical Snapshot of the Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rapid Growth in the Geriatric and Obese Populations and the Associated Increase in the Prevalence of Osteoarthritis
5.2.1.2 Increasing Incidence of Sports Injuries
5.2.2 Restraints
5.2.2.1 Risk of Adverse Cardiovascular Events Associated With the Use of Nsaids in Osteoarthritis Treatment
5.2.3 Opportunities
5.2.3.1 Emerging Markets
5.2.3.2 Strategic Collaborations Focused on New Product Development
5.2.4 Challenges
5.2.4.1 Availability of Alternative Non-Drug Pain Management Therapies

6 Osteoarthritis Therapeutics Market, By Anatomy
6.1 Introduction
6.2 Knee Osteoarthritis
6.2.1 Rising Obese and Geriatric Populations to Increase the Prevalence of Knee Osteoarthritis
6.3 Hip Osteoarthritis
6.3.1 Similar to Knee Osteoarthritis, Hip Osteoarthritis is More Common in the Geriatric and Obese Populations
6.4 Hand Osteoarthritis
6.4.1 Rising Prevalence of Shoulder Osteoarthritis to Drive Market Growth
6.5 Small-Joint Osteoarthritis
6.5.1 Rising Number of Ankle-Related Sports Injuries to Increase the Prevalence of Ankle Osteoarthritis

7 Osteoarthritis Therapeutics Market, By Drug Type
7.1 Introduction
7.2 Viscosupplementation Agents
7.2.1 Viscosupplementation Agents Dominated the Market in 2018
7.3 Nonsteroidal Anti-Inflammatory Drugs
7.3.1 Nsaids Can Relieve Pain and Inflammation Without the Various Potential Adverse Effects Associated With Corticosteroids
7.3.1.1 Ibuprofen
7.3.1.2 Diclofenac
7.3.1.3 Aspirin
7.3.1.4 Naproxen
7.3.1.5 Other Molecules
7.4 Analgesics
7.4.1 Acetaminophen
7.4.2 Duloxetine
7.5 Corticosteroids

8 Osteoarthritis Therapeutics Market, By Route of Administration
8.1 Introduction
8.2 Oral Route
8.3 Parenteral Route
8.4 Topical Route

9 Osteoarthritis Therapeutics Market, By Distribution Channel
9.1 Introduction
9.2 Hospital Pharmacies
9.3 Online Pharmacies
9.4 Retail Pharmacies

10 Osteoarthritis Therapeutics Market, By Purchasing Pattern
10.1 Introduction
10.2 Prescription Drugs
10.2.1 Prescription Drugs to Account for A Larger Share of the Market
10.3 Over-The-Counter Drugs
10.3.1 Ease of Purchase and Administration Resulting in A Rising Demand for Otc Drugs

11 Osteoarthritis Therapeutics Market, By Region
11.1 Introduction
11.2 Europe
11.2.1 Italy
11.2.2 Germany
11.2.3 Spain
11.2.4 France
11.2.5 UK
11.2.6 Rest of Europe
11.3 North America
11.3.1 US
11.3.2 Canada
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Rest of Asia Pacific
11.5 Rest of the World

12 Competitive Landscape
12.1 Overview
12.2 Market Ranking Analysis, 2018
12.3 Competitive Scenario
12.3.1 Product Launches and Approvals, 2016–2019
12.3.2 Collaborations, 2016–2019
12.3.3 Expansions, 2016–2019
12.3.4 Acquisitions, 2016–2019
12.3.5 Other Developments
12.4 Competitive Leadership Mapping
12.4.1 Vendor Inclusion Criteria
12.4.2 Visionary Leaders
12.4.3 Innovators
12.4.4 Dynamic Differentiators
12.4.5 Emerging Companies

13 Company Profiles
(Business Overview, Products Offered, Recent Developments, MnM View)*
13.1 Sanofi
13.2 Horizon Therapeutics PLC
13.3 Johnson & Johnson
13.4 Glaxosmithkline PLC
13.5 Bayer AG
13.6 Abbott
13.7 Pfizer, Inc.
13.8 Eli Lilly
13.9 Anika Therapeutics, Inc.
13.10 Novartis
13.11 Ferring Pharmaceuticals
13.12 Bioventus
13.13 Zimmer Biomet Holdings, Inc.
13.14 Fidia Farmaceutici S.P.A.
13.15 Flexion Therapeutics, Inc.

*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.

14 Appendix
14.1 Discussion Guide
14.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
14.3 Available Customizations
14.4 Related Reports
14.5 Author Details

List of Tables

Table 1 Osteoarthritis Therapeutics Market, By Anatomy, 2017–2024 (USD Million)
Table 2 Knee Osteoarthritis Therapeutics Market, By Region, 2017–2024 (USD Million)
Table 3 Hip Osteoarthritis Therapeutics Market, By Region, 2017–2024 (USD Million)
Table 4 Hand Osteoarthritis Therapeutics Market, By Region, 2017–2024 (USD Million)
Table 5 Small-Joint Osteoarthritis Therapeutics Market, By Region, 2017–2024 (USD Million)
Table 6 Market, By Drug Type, 2017–2024 (USD Million)
Table 7 Market for Viscosupplementation Agents, By Region, 2017–2024 (USD Million)
Table 8 Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
Table 9 Market for Nonsteroidal Anti-Inflammatory Drugs, By Region, 2017–2024 (USD Million)
Table 10 Market for Ibuprofen, By Region, 2017–2024 (USD Million)
Table 11 Market for Diclofenac, By Region, 2017–2024 (USD Million)
Table 12 Market for Aspirin, By Region, 2017–2024 (USD Million)
Table 13 Market for Naproxen, By Region, 2017–2024 (USD Million)
Table 14 Market for Other Molecules, By Region, 2017–2024 (USD Million)
Table 15 Market for Analgesics, By Type, 2017–2024 (USD Million)
Table 16 Market for Analgesics, By Region, 2017–2024 (USD Million)
Table 17 Market for Acetaminophen, By Region, 2017–2024 (USD Million)
Table 18 Market for Duloxetine, By Region, 2017–2024 (USD Million)
Table 19 Market for Corticosteroids, By Region, 2017–2024 (USD Million)
Table 20 Market, By Route of Administration, 2017–2024 (USD Million)
Table 21 Market for Oral Route of Administration, By Region, 2017–2024 (USD Million)
Table 22 Market for Parenteral Route of Administration, By Region, 2017–2024 (USD Million)
Table 23 Market for Topical Route of Administration, By Region, 2017–2024 (USD Million)
Table 24 Market, By Distribution Channel, 2017–2024 (USD Million)
Table 25 Market for Hospital Pharmacies, By Region, 2017–2024 (USD Million)
Table 26 Market for Online Pharmacies, By Region, 2017–2024 (USD Million)
Table 27 Market for Retail Pharmacies, By Region, 2017–2024 (USD Million)
Table 28 Market, By Purchasing Pattern, 2017–2024 (USD Million)
Table 29 Market for Prescription Drugs, By Region, 2017–2024 (USD Million)
Table 30 Market for Over-The-Counter Drugs, By Region, 2017–2024 (USD Million)
Table 31 Market, By Region, 2017–2024 (USD Million)
Table 32 Europe: Market, By Country, 2017–2024 (USD Million)
Table 33 Europe: Market, By Anatomy, 2017–2024 (USD Million)
Table 34 Europe: Market, By Drug Type, 2017–2024 (USD Million)
Table 35 Europe: Market for Analgesics, By Type, 2017–2024 (USD Million)
Table 36 Europe: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
Table 37 Europe: Market, By Route of Administration, 2017–2024 (USD Million)
Table 38 Europe: Market, By Distribution Channel, 2017–2024 (USD Million)
Table 39 Europe: Market, By Purchasing Pattern, 2017–2024 (USD Million)
Table 40 Italy: Market, By Anatomy, 2017–2024 (USD Million)
Table 41 Italy: Market, By Drug Type, 2017–2024 (USD Million)
Table 42 Italy: Market for Analgesics, By Type, 2017–2024 (USD Million)
Table 43 Italy: Osteoarthritis Therapeutics Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
Table 44 Italy: Market, By Route of Administration, 2017–2024 (USD Million)
Table 45 Italy: Market, By Distribution Channel, 2017–2024 (USD Million)
Table 46 Italy: Market, By Purchasing Pattern, 2017–2024 (USD Million)
Table 47 Germany: Market, By Anatomy, 2017–2024 (USD Million)
Table 48 Germany: Market, By Drug Type, 2017–2024 (USD Million)
Table 49 Germany: Market for Analgesics, By Type, 2017–2024 (USD Million)
Table 50 Germany: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
Table 51 Germany: Market, By Route of Administration, 2017–2024 (USD Million)
Table 52 Germany: Market, By Distribution Channel, 2017–2024 (USD Million)
Table 53 Germany: Market, By Purchasing Pattern, 2017–2024 (USD Million)
Table 54 Spain: Market, By Anatomy, 2017–2024 (USD Million)
Table 55 Spain: Market, By Drug Type, 2017–2024 (USD Million)
Table 56 Spain: Market for Analgesics, By Type, 2017–2024 (USD Million)
Table 57 Spain: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
Table 58 Spain: Market, By Route of Administration, 2017–2024 (USD Million)
Table 59 Spain: Market, By Distribution Channel, 2017–2024 (USD Million)
Table 60 Spain: Market, By Purchasing Pattern, 2017–2024 (USD Million)
Table 61 France: Market, By Anatomy, 2017–2024 (USD Million)
Table 62 France: Market, By Drug Type, 2017–2024 (USD Million)
Table 63 France: Market for Analgesics, By Type, 2017–2024 (USD Million)
Table 64 France: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
Table 65 France: Market, By Route of Administration, 2017–2024 (USD Million)
Table 66 France: Osteoarthritis Therapeutics Market, By Distribution Channel, 2017–2024 (USD Million)
Table 67 France: Market, By Purchasing Pattern, 2017–2024 (USD Million)
Table 68 UK: Market, By Anatomy, 2017–2024 (USD Million)
Table 69 UK: Market, By Drug Type, 2017–2024 (USD Million)
Table 70 UK: Market for Analgesics, By Type, 2017–2024 (USD Million)
Table 71 UK: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
Table 72 UK: Market, By Route of Administration, 2017–2024 (USD Million)
Table 73 UK: Market, By Distribution Channel, 2017–2024 (USD Million)
Table 74 UK: Market, By Purchasing Pattern, 2017–2024 (USD Million)
Table 75 RoE: Market, By Anatomy, 2017–2024 (USD Million)
Table 76 RoE: Market, By Drug Type, 2017–2024 (USD Million)
Table 77 RoE: Market for Analgesics, By Type, 2017–2024 (USD Million)
Table 78 RoE: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
Table 79 RoE: Market, By Route of Administration, 2017–2024 (USD Million)
Table 80 RoE: Market, By Distribution Channel, 2017–2024 (USD Million)
Table 81 RoE: Market, By Purchasing Pattern, 2017–2024 (USD Million)
Table 82 North America: Market, By Country, 2017–2024 (USD Million)
Table 83 North America: Osteoarthritis Therapeutics Market, By Anatomy, 2017–2024 (USD Million)
Table 84 North America: Market, By Drug Type, 2017–2024 (USD Million)
Table 85 North America: Market for Analgesics, By Type, 2017–2024 (USD Million)
Table 86 North America: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
Table 87 North America: Market, By Route of Administration, 2017–2024 (USD Million)
Table 88 North America: Market, By Distribution Channel, 2017–2024 (USD Million)
Table 89 North America: Market, By Purchasing Pattern, 2017–2024 (USD Million)
Table 90 US: Market, By Anatomy, 2017–2024 (USD Million)
Table 91 US: Market, By Drug Type, 2017–2024 (USD Million)
Table 92 US: Market for Analgesics, By Type, 2017–2024 (USD Million)
Table 93 US: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
Table 94 US: Market, By Route of Administration, 2017–2024 (USD Million)
Table 95 US: Market, By Distribution Channel, 2017–2024 (USD Million)
Table 96 US: Market, By Purchasing Pattern, 2017–2024 (USD Million)
Table 97 Canada: Market, By Anatomy, 2017–2024 (USD Million)
Table 98 Canada: Market, By Drug Type, 2017–2024 (USD Million)
Table 99 Canada: Market for Analgesics, By Type, 2017–2024 (USD Million)
Table 100 Canada: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
Table 101 Canada: Market, By Route of Administration, 2017–2024 (USD Million)
Table 102 Canada: Osteoarthritis Therapeutics Market, By Distribution Channel, 2017–2024 (USD Million)
Table 103 Canada: Market, By Purchasing Pattern, 2017–2024 (USD Million)
Table 104 Asia Pacific: Market, By Country, 2017–2024 (USD Million)
Table 105 Asia Pacific: Market, By Anatomy, 2017–2024 (USD Million)
Table 106 Asia Pacific: Market, By Drug Type, 2017–2024 (USD Million)
Table 107 Asia Pacific: Market for Analgesics, By Type, 2017–2024 (USD Million)
Table 108 Asia Pacific: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
Table 109 Asia Pacific: Market, By Route of Administration, 2017–2024 (USD Million)
Table 110 Asia Pacific: Market, By Distribution Channel, 2017–2024 (USD Million)
Table 111 Asia Pacific: Market, By Purchasing Pattern, 2017–2024 (USD Million)
Table 112 Japan: Market, By Anatomy, 2017–2024 (USD Million)
Table 113 Japan: Market, By Drug Type, 2017–2024 (USD Million)
Table 114 Japan: Market for Analgesics, By Type, 2017–2024 (USD Million)
Table 115 Japan: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
Table 116 Japan: Market, By Route of Administration, 2017–2024 (USD Million)
Table 117 Japan: Market, By Distribution Channel, 2017–2024 (USD Million)
Table 118 Japan: Market, By Purchasing Pattern, 2017–2024 (USD Million)
Table 119 China: Osteoarthritis Therapeutics Market, By Anatomy, 2017–2024 (USD Million)
Table 120 China: Market, By Drug Type, 2017–2024 (USD Million)
Table 121 China: Market for Analgesics, By Type, 2017–2024 (USD Million)
Table 122 China: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
Table 123 China: Market, By Route of Administration, 2017–2024 (USD Million)
Table 124 China: Market, By Distribution Channel, 2017–2024 (USD Million)
Table 125 China: Market, By Purchasing Pattern, 2017–2024 (USD Million)
Table 126 India: Market, By Anatomy, 2017–2024 (USD Million)
Table 127 India: Market, By Drug Type, 2017–2024 (USD Million)
Table 128 India: Market for Analgesics, By Type, 2017–2024 (USD Million)
Table 129 India: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
Table 130 India: Market, By Route of Administration, 2017–2024 (USD Million)
Table 131 India: Market, By Distribution Channel, 2017–2024 (USD Million)
Table 132 India: Market, By Purchasing Pattern, 2017–2024 (USD Million)
Table 133 RoAPAC: Market, By Anatomy, 2017–2024 (USD Million)
Table 134 RoAPAC: Market, By Drug Type, 2017–2024 (USD Million)
Table 135 RoAPAC: Market for Analgesics, By Type, 2017–2024 (USD Million)
Table 136 RoAPAC: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
Table 137 RoAPAC: Osteoarthritis Therapeutics Market, By Route of Administration, 2017–2024 (USD Million)
Table 138 RoAPAC: Market, By Distribution Channel, 2017–2024 (USD Million)
Table 139 RoAPAC: Market, By Purchasing Pattern, 2017–2024 (USD Million)
Table 140 RoW: Market, By Anatomy, 2017–2024 (USD Million)
Table 141 RoW: Market, By Drug Type, 2017–2024 (USD Million)
Table 142 RoW: Market for Analgesics, By Type, 2017–2024 (USD Million)
Table 143 RoW: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
Table 144 RoW: Market, By Route of Administration, 2017–2024 (USD Million)
Table 145 RoW: Market, By Distribution Channel, 2017–2024 (USD Million)
Table 146 RoW: Market, By Purchasing Pattern, 2017–2024 (USD Million)

List of Figures

Figure 1 Osteoarthritis Therapeutics Market Segmentation
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Market: Bottom-Up Approach
Figure 5 Market: Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Market, By Anatomy, 2019 vs 2024 (USD Billion)
Figure 8 Market, By Drug Type, 2019 vs 2024 (USD Billion)
Figure 9 Market, By Route of Administration, 2019 vs 2024 (USD Billion)
Figure 10 Osteoarthritis Therapeutics Market, By Distribution Channel, 2019 vs 2024 (USD Billion)
Figure 11 Market, By Purchasing Pattern, 2019 vs 2024 (USD Billion)
Figure 12 Market, By Region, 2019 vs 2024 (USD Billion)
Figure 13 High and Growing Prevalence of Osteoarthritis is the Major Factor Driving the Growth of This Market
Figure 14 Knee Osteoarthritis Therapeutics Segment to Dominate the European Market in 2019
Figure 15 China to Register the Highest CAGR During the Forecast Period
Figure 16 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 17 Geriatric Population, By Region, 2017 vs 2050
Figure 18 Europe: Osteoarthritis Therapeutics Market Snapshot
Figure 19 Asia Pacific: Market Snapshot
Figure 20 Key Developments in the Market From January 2016 to August 2019
Figure 21 Top 5 Companies in the Market
Figure 22 Global Market: Competitive Leadership Mapping, 2019
Figure 23 Sanofi: Company Snapshot (2018)
Figure 24 Horizon Therapeutics PLC: Company Snapshot (2018)
Figure 25 Johnson & Johnson: Company Snapshot (2018)
Figure 26 Glaxosmithkline PLC: Company Snapshot
Figure 27 Bayer AG: Company Snapshot (2018)
Figure 28 Abbott: Company Snapshot (2018)
Figure 29 Pfizer, Inc.: Company Snapshot (2018)
Figure 30 Eli Lilly: Company Snapshot (2018)
Figure 31 Anika Therapeutics, Inc.: Company Snapshot (2018)
Figure 32 Novartis: Company Snapshot (2018)
Figure 33 Zimmer Biomet Holdings, Inc.: Company Snapshot (2018)
Figure 34 Flexion Therapeutics: Company Snapshot (2018)

  • Global Microbiome Therapeutics Market Growth (Status and Outlook) 2019-2024
    Published: 15-Nov-2019        Price: US 3660 Onwards        Pages: 157
    According to this study, over the next five years the Microbiome Therapeutics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Microbiome Therapeutics business, shared in Chapter 3. This report presents a comprehensive overview, market shares and growth opportunities of Microbiome Therapeutics market by p......
  • 2017-2025 World Gout Therapeutics Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 14-Nov-2019        Price: US 2800 Onwards        Pages: 145
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. The report includes as follows: The report provides current data, historical overview and future forecast. The report includes an in-depth analysis of the Global market for Gout Therapeutics , covering Global total and ma......
  • Global Brachytherapy Afterloader Seeds Market Study 2016-2026, by Segment (HDR Afterloaders, PDR Afterloaders) , by Market (Prostate cancer, Gynecological Cancer,) , by Company (Elekta, Theragenics,)
    Published: 12-Nov-2019        Price: US 1800 Onwards        Pages: 50
    Summary Brachytherapy also known as internal radiotherapy, sealed source radiotherapy, curie therapy or endocurietherapy, is a form of radiotherapy where a sealed radiation source is placed inside or next to the area requiring treatment. Brachytherapy is commonly used as an effective treatment for cervical, prostate, breast, and skin cancer and can also be used to treat tumors in many other body sites.Brachytherapy Afterloaders, is kind of machine used in brachytherapy to delivere......
  • Global Hemoglobinopathies Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    Published: 12-Nov-2019        Price: US 3480 Onwards        Pages: 108
    Scope of the Report: The global Hemoglobinopathies market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United State......
  • Global Infantile Spasms Therapeutics Market Study 2016-2026, by Segment (Oral, Injection) , by Market (Hospital, Clinic,) , by Company (H. Lundbeck, Mallinckrodt,)
    Published: 11-Nov-2019        Price: US 1800 Onwards        Pages: 49
    Summary An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending for......
  • 2017-2025 World Enzyme Replacement Therapy Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 09-Nov-2019        Price: US 2800 Onwards        Pages: 106
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. The report includes as follows: The report provides current data, historical overview and future forecast. The report includes an in-depth analysis of the Global market for Enzyme Replacement Therapy , covering Gl......
  • Global Virus Like Particles Market Study 2016-2026, by Segment (Adeno-Associated Virus, HIV,) , by Market (Vaccines, Mycoviruses,) , by Company (GlaxoSmithKline, Merck,)
    Published: 08-Nov-2019        Price: US 1800 Onwards        Pages: 61
    Summary The global Virus Like Particles market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026. Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.): - Adeno-Associated Virus - HIV - Hepatitis B Virus - Hepatitis C Virus - Others Demand Coverage (Market Size & Forecast, Consumer Distribution): - Vaccines - Mycoviruses - Virus Research......
  • Global Clostridium Difficile Treatment Market Professional Survey Report 2019
    Published: 08-Nov-2019        Price: US 3500 Onwards        Pages: 110
    The global Clostridium Difficile Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Clostridium Difficile Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Clostridium Difficile Treatment market size by analyzing historical data and future prospect. Regionally, this report categoriz......
  • Global Venous Leg Ulcers Treatment Market Study 2016-2026, by Segment (CureXcell, CVBT-141B, ) , by Market (Hospital, Clinic, ) , by Company (CardioVascular BioTherapeutics Inc, CytoTools AG, )
    Published: 07-Nov-2019        Price: US 1800 Onwards        Pages: 53
    Summary The global Venous Leg Ulcers Treatment market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026. Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.): - CureXcell - CVBT-141B - Granexin - HP-802247 - Others Demand Coverage (Market Size & Forecast, Consumer Distribution): - Hospital - Clinic - Home Use Company Coverage......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs